American International Group, Inc. Bolt Biotherapeutics, Inc. Transaction History

American International Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.41 - $2.91 $16,021 - $33,066	-11,363 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.74 - $4.82 $2,189 - $3,851	-799 Reduced 6.57%	11,363 $31,000
Q4 2021 Feb 11, 2022	SELL	$4.19 - $13.97 $1,525 - $5,085	-364 Reduced 2.91%	12,162 $60,000
Q3 2021 Nov 12, 2021	BUY	$11.15 - $18.6 $67,178 - $112,065	6,025 Added 92.68%	12,526 $158,000
Q2 2021 Aug 13, 2021	SELL	$15.4 - $31.46 $13,736 - $28,062	-892 Reduced 12.07%	6,501 $101,000
Q1 2021 May 07, 2021	BUY	$25.86 - $39.93 $191,182 - $295,202	7,393 New	7,393 $243,000

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $18.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.